李贵森 . 2019年《中国慢性肾脏病矿物质和骨异常诊治指南》解读[J]. 诊断学理论与实践, 2020 , 19(03) : 229 -231 . DOI: 10.16150/j.1671-2870.2020.03.005
[1] | Moe S, Drüeke T, Cunningham J, et al. Definition, evalua-tion, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes(KDIGO)[J]. Kidney Int, 2006, 69(11):1945-1953. |
[2] | Kidney Disease: Improving Global Outcomes KDIGO CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J]. Kidney Int Suppl, 2009,(113):S1-S130. |
[3] | Kidney Disease: Improving Global Outcomes KDIGO CKD-MBD Update Work Group. KDIG O2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)[J]. Kidney Int Suppl, 2017, 7(1):1-59. |
[4] | 王莉, 李贵森, 刘志红. 中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J]. 肾脏病与透析肾移植杂志, 2013, 22(6):554-559. |
[5] | 刘志红, 李贵森. 中国慢性肾脏病矿物质和骨异常诊治指南[J]. 北京:人民卫生出版社, 2018. |
[6] | Liu ZH, Yu XQ, Yang JW, et al. Prevalence and risk factors for vascular calcification in Chinese patients recei-ving dialysis: Baseline results from a prospective cohort study[J]. Curr Med Res Opin, 2018, 34(8):1491-1500. |
[7] | 任松, 许明杰, 孟祥龙, 等. 强化教育对维持性血液透析患者高磷血症影响的meta分析[J]. 肾脏病与透析肾移植杂志, 2018, 27(2):135-140. |
[8] | 张小红, 陈财铭, 万建新. 非透析慢性肾脏病患者骨量异常与血管钙化的危险因素[J]. 中华肾脏病杂志, 2017, 33(2):100-105. |
[9] | Bucur RC, Panjwani DD, Turner L, et al. Low bone mine-ral density and fractures in stages 3-5 CKD: An updated systematic review and meta-analysis[J]. Osteoporos Int, 2015, 26(2):449-458. |
[10] | Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: A meta-analysis[J]. Am J Kidney Dis, 2007, 49(5):674-681. |
/
〈 |
|
〉 |